# Instinct Bio Technical Company Holdings Inc. (BIOT)

Source: https://www.quantisnow.com/company/BIOT
Generated: 2026-11-18T13:31:11.293Z

- Ticker: BIOT
- Exchange: NASDAQ
- Sector: Consumer Discretionary
- Industry: Package Goods/Cosmetics
- IPO year: 2021
- SEC CIK: 0002072188

## About

INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) is a diversified healthcare and biotechnology company focused on developing and expanding businesses across beauty, wellness, regenerative medicine and related healthcare sectors. Through its operations and strategic partnerships, BIOT seeks to build an integrated platform connecting innovative healthcare technologies, products and services with growth opportunities across Asia and other international markets.

## Latest BIOT news and filings

- 2026-11-10 21:53 UTC [SEC Schedule 13G] [SEC Form SCHEDULE 13G filed by Instinct Bio Technical Company Holdings Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-instinct-bio-technical-company-6784540)
- 2026-10-16 13:42 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biotech-acquisition-company-6748870)
- 2026-10-01 10:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biotech-acquisition-company-6731227)
- 2026-09-15 12:44 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biotech-acquisition-company-6715546)
- 2026-09-08 10:02 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biotech-acquisition-company-6707228)
- 2026-09-04 11:00 UTC [INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives](https://www.quantisnow.com/insight/instinct-bio-provides-operational-update-on-indonesia-growth-platform-and-6706175)
- 2026-08-10 15:04 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biotech-acquisition-company-6673212)
- 2026-08-10 11:00 UTC [Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia](https://www.quantisnow.com/insight/instinct-bio-announces-strategic-collaboration-with-pt-parva-candela-to-6672565)
- 2026-07-31 13:43 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biotech-acquisition-company-6657417)
- 2026-07-30 12:23 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biotech-acquisition-company-6655213)
- 2026-07-29 14:28 UTC [BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets](https://www.quantisnow.com/insight/biot-to-launch-indonesias-first-subscription-model-beauty-clinics-under-its-6653075)
- 2026-07-28 22:08 UTC [SEC Form 20-F filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-20-f-filed-by-biotech-acquisition-company-6652345)
- 2026-07-28 13:24 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biotech-acquisition-company-6650982)
- 2026-07-23 20:54 UTC [SEC Form CERT filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-cert-filed-by-biotech-acquisition-company-6647422)
- 2026-07-23 20:15 UTC [Instinct Bio Completes Business Combination with Relativity Acquisition Corp. and Makes Its Nasdaq Debut Under the Ticker “BIOT” on July 24, 2026](https://www.quantisnow.com/insight/instinct-bio-completes-business-combination-with-relativity-acquisition-corp-and-6647101)
- 2026-07-23 16:28 UTC [SEC Form 8-A12B filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-8-a12b-filed-by-biotech-acquisition-company-6646725)
- 2026-03-05 22:00 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-biotech-acquisition-company-6433132)
- 2025-12-04 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-effect-filed-by-biotech-acquisition-company-6302662)
- 2025-11-25 21:48 UTC [SEC Form POS AM filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-biotech-acquisition-company-6293887)
- 2025-10-24 21:23 UTC [Amendment: SEC Form F-4/A filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/amendment-sec-form-f-4a-filed-by-biotech-acquisition-company-6244891)
- 2025-09-26 01:23 UTC [Amendment: SEC Form F-4/A filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/amendment-sec-form-f-4a-filed-by-biotech-acquisition-company-6212469)
- 2024-02-14 14:12 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Biotech Acquisition Company (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-biotech-acquisition-company-amendment-5260007)
- 2023-02-14 21:40 UTC [SEC Form 15-12G filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-biotech-acquisition-company-4064597)
- 2023-02-14 15:50 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Biotech Acquisition Company (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-biotech-acquisition-company-amendment-4057771)
- 2023-02-14 15:35 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-biotech-acquisition-company-4057579)
- 2023-02-13 20:47 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Biotech Acquisition Company (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-biotech-acquisition-company-amendment-4049712)
- 2023-02-13 19:11 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Biotech Acquisition Company (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-biotech-acquisition-company-amendment-4048747)
- 2023-02-02 21:55 UTC [SEC Form 25-NSE filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-biotech-acquisition-company-3997365)
- 2023-02-02 01:00 UTC [SEC Form 8-K] [Biotech Acquisition Company filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/biotech-acquisition-company-filed-sec-form-8-k-termination-of-a-3991479)
- 2023-02-02 05:47 UTC [Market Insight] [Reported Late Wednesday, Biotech Acquisition Company Announces Liquidation; Will Not Implement The Extension Of The Time Period The Company Has To Complete An Initial Business Combination](https://www.quantisnow.com/insight/reported-late-wednesday-biotech-acquisition-company-announces-liquidation-will-not-3991087)
- 2023-02-02 00:50 UTC [Public Offering] [Biotech Acquisition Company Announces Liquidation](https://www.quantisnow.com/insight/biotech-acquisition-company-announces-liquidation-3990876)
- 2023-01-27 18:18 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-biotech-acquisition-company-3966036)
- 2023-01-25 21:35 UTC [SEC Form 8-K] [Biotech Acquisition Company filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/biotech-acquisition-company-filed-sec-form-8-k-other-events-financial-3954971)
- 2023-01-25 17:12 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-biotech-acquisition-company-3953143)
- 2023-01-11 14:27 UTC [SEC Form 8-K] [Biotech Acquisition Company filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits](https://www.quantisnow.com/insight/biotech-acquisition-company-filed-sec-form-8-k-notice-of-delisting-3899897)
- 2023-01-05 05:31 UTC [Market Chatter] [Reported Late Wednesday, Biotech Acquisition Company Announces Plan For New Sponsor To Make Additional Contributions To Trust Account Upon Approval Of Proposed Extension Amendment](https://www.quantisnow.com/insight/reported-late-wednesday-biotech-acquisition-company-announces-plan-for-new-3874654)
- 2023-01-04 22:51 UTC [Public Offering] [Biotech Acquisition Company Announces Plan for New Sponsor to Make Additional Contributions to Trust Account Upon Approval of Proposed Extension Amendment](https://www.quantisnow.com/insight/biotech-acquisition-company-announces-plan-for-new-sponsor-to-make-3873549)
- 2023-01-04 20:19 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-biotech-acquisition-company-3870836)
- 2022-12-22 22:28 UTC [SEC Form 8-K] [Biotech Acquisition Company filed SEC Form 8-K: Entry into a Material Definitive Agreement](https://www.quantisnow.com/insight/biotech-acquisition-company-filed-sec-form-8-k-entry-into-a-3839554)
- 2022-12-21 22:15 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Biotech Acquisition Company](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-biotech-acquisition-company-3834851)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BIOT
- Earnings history: https://www.quantisnow.com/earnings/BIOT
- Dividend history: https://www.quantisnow.com/dividends/BIOT
- Insider transactions: https://www.quantisnow.com/insiders/BIOT
- Options chain: https://www.quantisnow.com/options/BIOT
- SEC 8-K filings only: https://www.quantisnow.com/company/BIOT/8-k
- RSS and alerts for BIOT: https://www.quantisnow.com/docs/rss-feeds.md
